2022
Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease.
European heart journal. Cardiovascular pharmacotherapy
PubMed • Publisher's siteResearch at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 80 publications
- Percutaneous Coronary Intervention , 43 publications
- Purinergic P2Y Receptor Antagonists , 42 publications
- Blood Platelets , 38 publications
Research activity
My publications
Filter publications
122 publications
2022
Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease.
Journal of thrombosis and thrombolysis
PubMed • Publisher's site2022
P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention.
Nature reviews. Cardiology
PubMed • Publisher's site2022
Patterns and Outcomes of Dual Antiplatelet Therapy Discontinuation After Percutaneous Coronary Intervention.
JACC. Cardiovascular interventions
PubMed • Publisher's site2022
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease.
Thrombosis and haemostasis
PubMed • Publisher's site